A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1

Clinical trial NCT00790673 · COMPLETED

Trial details

NCT number: NCT00790673
Sponsor: Can-Fite BioPharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2009-07-01
Primary completion: 2011-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.